SIC
RVMD icon

SJS Investment Consulting’s Revolution Medicines RVMD Stock Holding History

SJS Investment Consulting’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Buy
59
+49
+490% +$7.16K ﹤0.01% 1042
2026
Q1 		$973 Buy
10
+3
+43% +$303 ﹤0.01% 1483
2025
Q4 		$558 Buy
7
+3
+75% +$197 ﹤0.01% 1486
2025
Q3 		$187 Hold
4
– – ﹤0.01% 1481
2025
Q2 		$148 Buy
4
+1
+33% +$38 ﹤0.01% 1430
2025
Q1 		$107 Hold
3
– – ﹤0.01% 1519
2024
Q4 		$132 Hold
3
– – ﹤0.01% 1501
2024
Q3 		$137 Hold
3
– – ﹤0.01% 1548
2024
Q2 		$117 Hold
3
– – ﹤0.01% 1569
2024
Q1 		$97 Sell
3
-1
-25% -$30 ﹤0.01% 1570
2023
Q4 		$115 Sell
4
-4
-50% -$96 ﹤0.01% 1540
2023
Q3 		$222 Buy
8
+4
+100% +$119 ﹤0.01% 1438
2023
Q2 		$107 Buy
4
+2
+100% +$49 ﹤0.01% 1508
2023
Q1 		$44 Buy
+2
New +$49 ﹤0.01% 1528

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

SJS Investment Consulting's RVMD Position: Q2 2026 in Review

SJS Investment Consulting increased its Revolution Medicines (RVMD) stake by 490% in Q2 2026, buying an estimated $7.16K and bringing the position to 59 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1042.

SJS Investment Consulting first reported a position in RVMD in Q1 2023 and has held it in 14 quarters since. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • SJS Investment Consulting held 59 shares of Revolution Medicines worth $11.1K as of Q2 2026.
  • SJS Investment Consulting bought 49 Revolution Medicines shares in Q2 2026, an estimated $7.16K.
  • Revolution Medicines made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #1042 holding.
  • SJS Investment Consulting first reported a position in Revolution Medicines in Q1 2023 and has held it in 14 quarters since.
  • 693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.